DRUG · Mapped RxNorm record
Maraviroc
Normalized identity: maravirocView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV
NCT03129113
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Metformin
Normalized identity: metforminView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAdding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIV
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2, PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Hepatic Steatosisunresolved
HIV-1-infectionunresolved
Interventions
MaravirocDRUG · verified · RxNorm: maraviroc
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
University College, Londonlead sponsor
Medical Research Councilcollaborator
ViiV Healthcarecollaborator
Royal Free Hospital NHS Foundation Trustcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03129113 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.